We've compiled a list of the most common questions, along with answers from our experts
In March 2024, it became the first obesity medication to receive FDA approval for reducing the risk of cardiovascular events, reinforcing its role beyond weight loss
Weight loss is targeted at a rate of 1-3 lbs per week and works even for those who have a history of frequent or repeat dieting, weight loss resistance, difficulty maintaining weight loss, sugar and carb cravings, peri-menopausal or post-menopausal weight gain, and poor blood sugar control
Preparation and therapeutic evaluation of engineered semaglutide and statin-lipid conjugate-based nanoparticle
Metabolic syndrome (a cluster of conditions that increases the risk of developing type 2 diabetes) has also been linked to alopecia, aka hair loss